Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
134,558,175
-
Total 13F shares
-
69,654,865
-
Share change
-
+1,903,088
-
Total reported value
-
$527,984,476
-
Price per share
-
$7.58
-
Number of holders
-
69
-
Value change
-
+$13,372,743
-
Number of buys
-
40
-
Number of sells
-
17
Institutional Holders of Tango Therapeutics, Inc. - Common Stock (TNGX) as of Q1 2022
As of 31 Mar 2022,
Tango Therapeutics, Inc. - Common Stock (TNGX) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,654,865 shares.
The largest 10 holders included
TRV GP IV, LLC, FMR LLC, BOXER CAPITAL, LLC, Casdin Capital, LLC, Cormorant Asset Management, LP, Southpoint Capital Advisors LP, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, L.P., Bain Capital Life Sciences Investors, LLC, and Avoro Capital Advisors LLC.
This page lists
69
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.